CHINA RES PHARMACEUTICAL GROUP LTD. revenue for the last year amounted to 34.47 B USD, the most of which — 25.08 B USD — came from its highest performing source at the moment, Distribution, the year earlier bringing 26.25 B USD. The greatest contribution to the revenue figure was made by China — last year it brought CHINA RES PHARMACEUTICAL GROUP LTD. 31.13 B USD, and the year before that — 32.45 B USD.